| Systematic (IUPAC) name | |
|---|---|
| [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | topical |
| Identifiers | |
| CAS number | 5593-20-4 |
| ATC code | ? |
| PubChem | CID 21800 |
| ChemSpider | 20490 |
| ChEMBL | CHEMBL1200384 |
| Synonyms | Betamethasone-17,21-dipropionate |
| Chemical data | |
| Formula | C28H37FO7 |
| Mol. mass | 504.59 g/mol |
| SMILES | eMolecules & PubChem |
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive abilities. It is applied as a topical cream, ointment, lotion or gel (Diprolene) to treat itching and other minor skin conditions such as eczema.
Brand names include Alphatrex, Beta-Val, Diprolene, Diprolene AF, Diprosone, and Luxiq.
Minor side-effects include dry skin and mild temporary stinging when applied.[1]